Amgen’s executive in Puerto Rico showcases the site’s global biotech standards and potential under the ‘Made in America’ platform. With the right strategy, Puerto Rico’s manufacturing sector can thrive and attract more business, leveraging its strong asset status over the last three decades. The island’s unique position and collaborative efforts could ensure sustained growth in the biotech industry.
– Amgen executive emphasizes Puerto Rico’s global biotech standards
– Potential for growth under ‘Made in America’ platform
– Manufacturing sector can thrive with right strategy
– Island’s unique position and collaborative efforts key for sustained industry growth
Read more from newsismybusiness.com